ATE108906T1 - Methode zur bestimmung des verhaltens von medikamenten in lebewesen. - Google Patents

Methode zur bestimmung des verhaltens von medikamenten in lebewesen.

Info

Publication number
ATE108906T1
ATE108906T1 AT88115581T AT88115581T ATE108906T1 AT E108906 T1 ATE108906 T1 AT E108906T1 AT 88115581 T AT88115581 T AT 88115581T AT 88115581 T AT88115581 T AT 88115581T AT E108906 T1 ATE108906 T1 AT E108906T1
Authority
AT
Austria
Prior art keywords
drugs
animal
behavior
drug
determining
Prior art date
Application number
AT88115581T
Other languages
English (en)
Inventor
Hiroyuki Inst Of Bio-Ac Ohhara
- Kinashi Aza Kawakitaya Pharm
Akio Inst Of Bio-Act Namimatsu
Hirohide Inst Of Bio- Matsuura
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE108906T1 publication Critical patent/ATE108906T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88115581T 1987-09-22 1988-09-22 Methode zur bestimmung des verhaltens von medikamenten in lebewesen. ATE108906T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62238006A JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine

Publications (1)

Publication Number Publication Date
ATE108906T1 true ATE108906T1 (de) 1994-08-15

Family

ID=17023739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88115581T ATE108906T1 (de) 1987-09-22 1988-09-22 Methode zur bestimmung des verhaltens von medikamenten in lebewesen.

Country Status (5)

Country Link
US (1) US4996988A (de)
EP (1) EP0308926B1 (de)
JP (1) JPS6479657A (de)
AT (1) ATE108906T1 (de)
DE (1) DE3850728T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234965B1 (en) * 1998-03-31 2001-05-22 Scientific Learning Corporation Methods and apparatus for improving biochemical based therapy in humans
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
CN101528947A (zh) * 2006-09-06 2009-09-09 日本脏器制药株式会社 通过基因表达分析进行研究、判定或评价的方法
WO2011017835A1 (en) * 2009-08-11 2011-02-17 Nanjing University Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
JP6469002B2 (ja) 2013-04-30 2019-02-13 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤
US20150031004A1 (en) 2013-07-24 2015-01-29 Lumos Labs, Inc. Physically intuitive, real-time, multiple object tracking, planning and divided attention task for enhancing cognition
US20200338135A1 (en) * 2017-12-28 2020-10-29 Hyogo College Of Medicine Lipocalin-type prostaglandin d2 synthase production promoting agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU506395A1 (ru) * 1974-06-10 1976-03-15 Всесоюзный научно-исследовательский институт ветеринарной санитарии Способ токсикологического исследовани м са животных, вынужденно забитых при фузариотоксикозе
SU656099A1 (ru) * 1977-09-06 1979-04-05 Научно-Исследовательский Институт Эпидемиологии, Микробиологии И Инфекционных Болезней Способ моделировани реакций клеточной гиперчувствительности
SU1076810A1 (ru) * 1981-05-29 1984-02-29 Институт питания АМН СССР Способ определени безвредности продуктов питани
US4537747A (en) * 1983-03-16 1985-08-27 Chemetrics, Inc. Disposable device for sampling and diluting
US4535786A (en) * 1983-07-25 1985-08-20 Kater John A R Measurement of body fluid chemistry
SU1187793A1 (ru) * 1984-01-31 1985-10-30 Do G Med I Im A M Gorkogo Способ диагностики острого панкреатита
US4677968A (en) * 1986-01-14 1987-07-07 University Of Utah Research Foundation Methods of testing the reaction of various substances on living human skin

Also Published As

Publication number Publication date
EP0308926B1 (de) 1994-07-20
DE3850728D1 (de) 1994-08-25
DE3850728T2 (de) 1994-12-22
JPS6479657A (en) 1989-03-24
EP0308926A2 (de) 1989-03-29
EP0308926A3 (en) 1990-07-11
US4996988A (en) 1991-03-05
JPH0565106B2 (de) 1993-09-17

Similar Documents

Publication Publication Date Title
DE69533942D1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
ATE268477T1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
Perlmann et al. Changes in the electrophoretic pattern in lymph and serum in experimental burns
DE69130289D1 (de) Therapeutische verwendung von actin-bindenden verbindungen
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
ATE108906T1 (de) Methode zur bestimmung des verhaltens von medikamenten in lebewesen.
ATE242005T1 (de) P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes
ATE123381T1 (de) Verabreichung von wirkstoffen zu wassertieren mittels überschallen.
Pool et al. Ethionine-induced depression of plasma antihemophilic globulin in the rat
Borlongan Motor activity-mediated partial recovery in ischemic rats
Oestreicher et al. Characterization of Infant Rat Cerebral Cortical Membrane Proteins Phosphorylated In Vivo: Identification of the ACTH‐Sensitive Phosphoprotein B‐50
Pratiwi et al. The effect of nanochitosan from rhinoceros beetle (Xylotrupes gideon) towards GIC surface roughness on critical pH of the saliva
Pai et al. Kinetics of aluminum in rats I: Dose‐dependent elimination from blood after intravenous administration
Mulvihill et al. An investigation of factors influencing the bioavailability of non-heam iron from meat systems
Bernacka et al. Alpha-2A but not 2B/C noradrenergic receptors in ventral tegmental area regulate phasic dopamine release in nucleus accumbens core
SE8701437D0 (sv) Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet
KUKRAL et al. Hepatic function after canine liver transplantation
Johnsonbaugh et al. Exercise tolerance test: single-sample screening technique to rule out growth-hormone deficiency
Dawes et al. Stop-flow effects on human salivary composition and hydrostatic pressures
EP1804789A4 (de) Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin
RU94025667A (ru) Способ оценки годности биопрепарата
van den Besselaar Standardization of the activated partial thromboplastin time for monitoring of heparin therapy: where should we go?
MX2024002920A (es) Formulaciones farmaceuticas inyectables de alta concentracion y metodos de preparacion y uso de las mismas.
Popiel et al. Antipruritic application of ovocystatin in atopic dermatitis in dogs-preliminary study

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties